FDA has approved an Investigational Device Exempti
Post# of 41
(Total Views: 35)
Posted On: 04/02/2025 10:57:25 AM
FDA has approved an Investigational Device Exemption (IDE) application to initiate a pilot study for the treatment of patients with recurrent glioblastoma (GBM) using the Alpha DaRT technology
https://www.alphatau.com/single-post/alpha-ta...ioblastoma
https://www.alphatau.com/single-post/alpha-ta...ioblastoma
(0)
(0)Alpha Tau Medical Ltd. (DRTS) Stock Research Links
Scroll down for more posts ▼